Literature DB >> 18719191

First case of post-endoscopic retrograde cholangiopancreatography bacteraemia caused by Acinetobacter ursingii in a patient with choledocholithiasis and cholangitis.

Victoria Ortiz de la Tabla Ducasse1, Coral Martín González1, Juan A Sáez-Nieto2, Félix Gutiérrez3.   

Abstract

We describe what we believe to be the first case of biliary sepsis caused by Acinetobacter ursingii. The patient was a healthy woman with no comorbidities who presented with choledocholithiasis and cholangitis. The performance of an endoscopic cholangiopancreatography was the trigger for A. ursingii bacteraemia. This report highlights the inadequacies of conventional phenotypic tests usually available in clinical microbiology laboratories for the identification of Acinetobacter species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719191     DOI: 10.1099/jmm.0.2008/002253-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

Review 1.  Two case reports of gastroendoscopy-associated Acinetobacter baumannii bacteremia.

Authors:  Chang-Hua Chen; Shun-Sheng Wu; Chieh-Chen Huang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

2.  Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

Authors:  P J van den Broek; T J K van der Reijden; E van Strijen; A V Helmig-Schurter; A T Bernards; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

3.  Acinetobacter baumannii bacteremia, a rare complication of endoscopic retrograde cholagiopancreatography!

Authors:  Hadoun Jabri; Devang Sanghavi; Sarbajit Mukherjee; Ema Dzaka-Dizdarevic; Nkemakolam Iroegbu
Journal:  Avicenna J Med       Date:  2014-04

4.  Draft Genome Sequencing of an Acinetobacter ursingii Isolate from Healthy Human Skin, Carrying Multidrug Resistance Genes.

Authors:  Lenka Palkova; Gabriel Minarik; Katarina Soltys
Journal:  Genome Announc       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.